4//SEC Filing
Yablonka Uri 4
Accession 0001104659-21-151211
CIK 0001137883other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 5:01 PM ET
Size
5.8 KB
Accession
0001104659-21-151211
Insider Transaction Report
Form 4
Yablonka Uri
DirectorChief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2021-12-15+13,333→ 13,333 totalExercise: $0.75Exp: 2031-12-15→ Common Stock (13,333 underlying)
Footnotes (1)
- [F1]Option vests and become exercisable in 12 consecutive, equal monthly installments commencing on January 15, 2022 until fully vested and exercisable on the 12 month anniversary of December 15, 2021.
Documents
Issuer
BRAINSTORM CELL THERAPEUTICS INC.
CIK 0001137883
Entity typeother
Related Parties
1- filerCIK 0001608814
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 5:01 PM ET
- Size
- 5.8 KB